Shifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis.

Yeo, Yee Hui; Rezaie, Ali; Hsieh, Tina Yi-Jin; Hu, Xiaoqin; Gaddam, Srinivas; Ma, Kevin Sheng-Kai; Mohamed, Ghada; Lee, Gin Yi; Huang, Pin-Chia; Watson, Rabindra

Yeo, Yee Hui; Rezaie, Ali; Hsieh, Tina Yi-Jin; Hu, Xiaoqin; Gaddam, Srinivas; Ma, Kevin Sheng-Kai; Mohamed, Ghada; Lee, Gin Yi; Huang, Pin-Chia; Watson, Rabindra.

Affiliation

Yeo YH; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California.
Rezaie A; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California.
Hsieh TY; Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Hu X; Department of Infectious Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Gaddam S; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California.
Ma KS; Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ann Intern Med ; 177(9): 1289-1291, 2024 Sep.

Article de En | MEDLINE | ID: mdl-39038291

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Récepteur du peptide-1 similaire au glucagon / Hypoglycémiants Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Ann Intern Med Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google